~~<i id='0DEDCD9A2A'><strike id='0DEDCD9A2A'><tt id='0DEDCD9A2A'><pre id='0DEDCD9A2A'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：fashion 2025-09-27 18:43:23 Page View：39

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： CDC advisory group OKs chikungunya vaccine
Next article： Heart attack and stroke risk calculators need revising

leisure time

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Medicare isn't yet testing food as medicine

AdobeWASHINGTON–SometwelvepercentoftraditionalMedicarebeneficiarieshaveheartfailure.Roughlyaquarterh

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

Biden declares emergency in flood

LiveAgeneralviewofafloodedarea,inLudlow,Vt.,July10,2023.Instagram@henrysweatherchannel/viaReutersU.S